Annual D&A
$8.98 M
+$1.40 M+18.54%
December 31, 2023
Summary
- As of February 7, 2025, NTLA annual depreciation & amortization is $8.98 million, with the most recent change of +$1.40 million (+18.54%) on December 31, 2023.
- During the last 3 years, NTLA annual D&A has risen by +$2.67 million (+42.23%).
- NTLA annual D&A is now at all-time high.
Performance
NTLA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.61 M
+$9000.00+0.35%
September 30, 2024
Summary
- As of February 7, 2025, NTLA quarterly depreciation & amortization is $2.61 million, with the most recent change of +$9000.00 (+0.35%) on September 30, 2024.
- Over the past year, NTLA quarterly D&A has increased by +$318.00 thousand (+13.89%).
- NTLA quarterly D&A is now at all-time high.
Performance
NTLA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$10.19 M
+$318.00 K+3.22%
September 30, 2024
Summary
- As of February 7, 2025, NTLA TTM depreciation & amortization is $10.19 million, with the most recent change of +$318.00 thousand (+3.22%) on September 30, 2024.
- Over the past year, NTLA TTM D&A has increased by +$1.64 million (+19.25%).
- NTLA TTM D&A is now at all-time high.
Performance
NTLA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
NTLA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.5% | +13.9% | +19.3% |
| 3 y3 years | +42.2% | +46.0% | +54.0% |
| 5 y5 years | +101.1% | +88.6% | +82.3% |
NTLA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.3% | at high | +48.7% | at high | +47.8% |
| 5 y | 5-year | at high | +60.7% | at high | +69.2% | at high | +82.3% |
| alltime | all time | at high | +2636.6% | at high | +7803.0% | at high | >+9999.0% |
Intellia Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.61 M(+0.3%) | $10.19 M(+3.2%) |
| Jun 2024 | - | $2.60 M(+3.5%) | $9.87 M(+4.5%) |
| Mar 2024 | - | $2.51 M(+1.9%) | $9.44 M(+5.1%) |
| Dec 2023 | $8.98 M(+18.5%) | $2.47 M(+7.7%) | $8.98 M(+5.1%) |
| Sep 2023 | - | $2.29 M(+5.5%) | $8.54 M(+4.1%) |
| Jun 2023 | - | $2.17 M(+5.9%) | $8.20 M(+4.2%) |
| Mar 2023 | - | $2.05 M(+0.9%) | $7.87 M(+3.9%) |
| Dec 2022 | $7.57 M(+9.9%) | $2.03 M(+4.2%) | $7.57 M(+2.0%) |
| Sep 2022 | - | $1.95 M(+6.2%) | $7.42 M(+2.3%) |
| Jun 2022 | - | $1.84 M(+4.7%) | $7.26 M(+2.9%) |
| Mar 2022 | - | $1.75 M(-6.7%) | $7.05 M(+2.4%) |
| Dec 2021 | $6.89 M(+9.2%) | $1.88 M(+5.3%) | $6.89 M(+4.2%) |
| Sep 2021 | - | $1.79 M(+9.3%) | $6.61 M(+2.9%) |
| Jun 2021 | - | $1.63 M(+2.7%) | $6.43 M(+1.1%) |
| Mar 2021 | - | $1.59 M(-0.7%) | $6.36 M(+0.8%) |
| Dec 2020 | $6.31 M(+13.0%) | $1.60 M(0.0%) | $6.31 M(+0.6%) |
| Sep 2020 | - | $1.60 M(+2.3%) | $6.28 M(+3.6%) |
| Jun 2020 | - | $1.57 M(+1.6%) | $6.06 M(+3.9%) |
| Mar 2020 | - | $1.54 M(-1.6%) | $5.83 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $5.59 M(+25.2%) | $1.57 M(+13.2%) | $5.59 M(+6.5%) |
| Sep 2019 | - | $1.38 M(+3.4%) | $5.25 M(+4.6%) |
| Jun 2019 | - | $1.34 M(+2.9%) | $5.02 M(+5.6%) |
| Mar 2019 | - | $1.30 M(+5.9%) | $4.75 M(+6.5%) |
| Dec 2018 | $4.46 M(+49.1%) | $1.23 M(+6.5%) | $4.46 M(+9.7%) |
| Sep 2018 | - | $1.15 M(+7.4%) | $4.07 M(+9.8%) |
| Jun 2018 | - | $1.07 M(+6.0%) | $3.71 M(+10.8%) |
| Mar 2018 | - | $1.01 M(+21.5%) | $3.35 M(+11.8%) |
| Dec 2017 | $2.99 M(+171.2%) | $833.00 K(+5.4%) | $2.99 M(+16.7%) |
| Sep 2017 | - | $790.00 K(+11.1%) | $2.57 M(+25.7%) |
| Jun 2017 | - | $711.00 K(+7.7%) | $2.04 M(+29.4%) |
| Mar 2017 | - | $660.00 K(+63.0%) | $1.58 M(+42.8%) |
| Dec 2016 | $1.10 M(+236.6%) | $405.00 K(+52.8%) | $1.10 M(+32.9%) |
| Sep 2016 | - | $265.00 K(+7.3%) | $831.00 K(+25.5%) |
| Jun 2016 | - | $247.00 K(+32.1%) | $662.00 K(+37.3%) |
| Mar 2016 | - | $187.00 K(+41.7%) | $482.00 K(+47.0%) |
| Dec 2015 | $328.00 K | $132.00 K(+37.5%) | $328.00 K(+67.3%) |
| Sep 2015 | - | $96.00 K(+43.3%) | $196.00 K(+96.0%) |
| Jun 2015 | - | $67.00 K(+103.0%) | $100.00 K(+203.0%) |
| Mar 2015 | - | $33.00 K | $33.00 K |
FAQ
- What is Intellia Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Intellia Therapeutics?
- What is Intellia Therapeutics annual D&A year-on-year change?
- What is Intellia Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly D&A year-on-year change?
- What is Intellia Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Intellia Therapeutics?
- What is Intellia Therapeutics TTM D&A year-on-year change?
What is Intellia Therapeutics annual depreciation & amortization?
The current annual D&A of NTLA is $8.98 M
What is the all time high annual D&A for Intellia Therapeutics?
Intellia Therapeutics all-time high annual depreciation & amortization is $8.98 M
What is Intellia Therapeutics annual D&A year-on-year change?
Over the past year, NTLA annual depreciation & amortization has changed by +$1.40 M (+18.54%)
What is Intellia Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of NTLA is $2.61 M
What is the all time high quarterly D&A for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly depreciation & amortization is $2.61 M
What is Intellia Therapeutics quarterly D&A year-on-year change?
Over the past year, NTLA quarterly depreciation & amortization has changed by +$318.00 K (+13.89%)
What is Intellia Therapeutics TTM depreciation & amortization?
The current TTM D&A of NTLA is $10.19 M
What is the all time high TTM D&A for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM depreciation & amortization is $10.19 M
What is Intellia Therapeutics TTM D&A year-on-year change?
Over the past year, NTLA TTM depreciation & amortization has changed by +$1.64 M (+19.25%)